Sultopride
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Sultopride (trade names Barnetil, Barnotil, Topral) is an atypical antipsychotic of the benzamide chemical class used in Europe, Japan, and Hong Kong for the treatment of schizophrenia.[1][2][3] It was launched by Sanofi-Aventis in 1976.[1] Sultopride acts as a selective D2 and D3 receptor antagonist.[4] It has also been shown to have clinically relevant affinity for the GHB receptor as well, a property it shares in common with amisulpride and sulpiride.[5]
Pharmacology
| Site | Ki | Species | Ref |
|---|---|---|---|
| D2 | 1.6 | Human | [6] |
| D3 | 3.8 | Human | [6] |
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".